A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam
https://doi.org/10.4081/dr.2024.9899
Accepted: 10 March 2024
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
This study aims to evaluate the association between tumor necrosis factor-α (TNF–α) single nucleotide polymorphisms and psoriasis vulgaris. This cross-sectional study involved 140 Vietnamese patients of Kinh ethnicity diagnosed with psoriasis vulgaris. The diagnosis of psoriasis vulgaris was based on clinical signs and symptoms. We used Sanger sequencing to analyze two SNPs rs1799964 and rs1799724. Data were analyzed by SPSS 25. SNP rs1799964 has the highest rate of TT genotype at 62.1%, more than double the heterozygous TC genotype at 30%, CC genotype has the lowest rate at 7.9%. CC genotype of SNP rs1799724 accounted for 90% and no homozygous genotype TT was detected. No statistically significant association was found between both SNPs and clinical features (p >0.05). The Psoriasis Area and Severity Index (PASI) was significantly lower in patients with variant alleles (P =0.021). Our data show a significant negative association between SNPs variant alleles and disease’s severity. Studies with larger sample sizes and more biochemical indices may help identify reliably predictive markers for these SNPs.
Organization WH. Global report on psoriasis. 2016.
Michalek IM, Loring B and John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol 2017; 31: 205-212. 2016/08/31. DOI: 10.1111/jdv.13854. DOI: https://doi.org/10.1111/jdv.13854
Petit RG, Cano A, Ortiz A, et al. Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics. Int J Mol Sci 2021; 22 2021/06/03. DOI: 10.3390/ijms22094983. DOI: https://doi.org/10.3390/ijms22094983
Nedoszytko B, Szczerkowska-Dobosz A, Zablotna M, et al. Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population. Br J Dermatol 2007; 157: 165-167. 2007/06/08. DOI: 10.1111/j.1365-2133.2007.07993.x. DOI: https://doi.org/10.1111/j.1365-2133.2007.07993.x
Uyemura K, Yamamura M, Fivenson DF, et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol 1993; 101: 701-705. 1993/11/01. DOI: 10.1111/1523-1747.ep12371679. DOI: https://doi.org/10.1111/1523-1747.ep12371679
Wakui M. [Analysis of single nucleotide polymorphisms (SNPs)]. Rinsho byori The Japanese journal of clinical pathology 2013; 61: 1008-1017. 2014/01/24.
Wang DG, Fan JB, Siao CJ, et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998; 280: 1077-1082. 1998/06/06. DOI: 10.1126/science.280.5366.1077. DOI: https://doi.org/10.1126/science.280.5366.1077
El-Tahan RR, Ghoneim AM and El-Mashad N. TNF-α gene polymorphisms and expression. SpringerPlus 2016; 5: 1508. 2016/09/22. DOI: 10.1186/s40064-016-3197-y. DOI: https://doi.org/10.1186/s40064-016-3197-y
Higuchi T, Seki N, Kamizono S, et al. Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 1998; 51: 605-612. 1998/08/07. DOI: 10.1111/j.1399-0039.1998.tb03002.x. DOI: https://doi.org/10.1111/j.1399-0039.1998.tb03002.x
Shen C, Wang H, Song Q, et al. Tumor Necrosis Factor-alpha 308 G/A polymorphism and psoriasis risk: A pooled analysis in different populations. Medicine (Baltimore) 2020; 99: e22339. 2020/11/22. DOI: 10.1097/MD.0000000000022339. DOI: https://doi.org/10.1097/MD.0000000000022339
Cabaleiro T, Román M, Gallo E, et al. Association between psoriasis and polymorphisms in the TNF, IL12B, and IL23R genes in Spanish patients. Eur J Dermatol 2013; 23: 640-645. 2013/10/19. DOI: 10.1684/ejd.2013.2144. DOI: https://doi.org/10.1684/ejd.2013.2144
Reich K, Hüffmeier U, König IR, et al. TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF*-857 independent of the PSORS1 risk allele. Arthritis and rheumatism 2007; 56: 2056-2064. 2007/05/29. DOI: 10.1002/art.22590. DOI: https://doi.org/10.1002/art.22590
Rendon A and Schäkel K. Psoriasis Pathogenesis and Treatment. Int J Mol Sci 2019; 20 2019/03/27. DOI: 10.3390/ijms20061475. DOI: https://doi.org/10.3390/ijms20061475
Gallo E, Cabaleiro T, Román M, et al. [Study of genetic polymorphisms in the tumor necrosis factor α promoter region in Spanish patients with psoriasis]. Actas dermo-sifiliograficas 2012; 103: 301-307. 2011/12/23. DOI: 10.1016/j.ad.2011.10.002. DOI: https://doi.org/10.1016/j.adengl.2012.05.009
Gulel A, Inaloz HS, Nursal AF, et al. Association of the TNF-α, IL-2, and IL-2RB gene variants with susceptibility to psoriasis in a Turkish cohort. Cent Eur J Immunol 2018; 43: 50-57. 2018/05/08. DOI: 10.5114/ceji.2018.74873. DOI: https://doi.org/10.5114/ceji.2018.74873
Dapra V, Ponti R, Lo Curcio G, et al. Functional study of TNF-alpha as a promoter of polymorphisms in psoriasis. Ital J Dermatol Venerol 2022; 157: 146-153. 2021/05/14. DOI: 10.23736/S2784-8671.21.06979-0. DOI: https://doi.org/10.23736/S2784-8671.21.06979-0
Asadullah K, Prösch S, Audring H, et al. A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression. Br J Dermatol 1999; 141: 94-102. 1999/07/27. DOI: 10.1046/j.1365-2133.1999.02926.x. DOI: https://doi.org/10.1046/j.1365-2133.1999.02926.x
Jang DI, Lee AH, Shin HY, et al. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. Int J Mol Sci 2021; 22 2021/04/04. DOI: 10.3390/ijms22052719. DOI: https://doi.org/10.3390/ijms22052719
Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harbor perspectives in biology 2009; 1: a001651. 2010/05/12. DOI: 10.1101/cshperspect.a001651. DOI: https://doi.org/10.1101/cshperspect.a001651
Meephansan J, Subpayasarn, Urairack, Ohtsuki, Mayumi,. Pathogenic Role of Cytokines and Effect of Their Inhibition in Psoriasis. In: Anca Chiriac (ed) Psoriasis: An Interdisciplinary Approach to. 2017, pp.56-78. DOI: https://doi.org/10.5772/intechopen.68421
Yost J and Gudjonsson JE. The role of TNF inhibitors in psoriasis therapy: new implications for associated comorbidities. F1000 medicine reports 2009; 1 2009/01/01. DOI: 10.3410/m1-30. DOI: https://doi.org/10.3410/M1-30
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
